A citation-based method for searching scientific literature

Katherine Af Lang. Expert Rev Mol Diagn 2013
Times Cited: 2

List of co-cited articles
1 articles co-cited >1

Times Cited
  Times     Co-cited

The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience.
Caitlin B Mauer, Sara M Pirzadeh-Miller, Linda D Robinson, David M Euhus. Genet Med 2014

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998

The evolution of cancer risk assessment in the era of next generation sequencing.
Heather Fecteau, Kristen J Vogel, Kristen Hanson, Shannon Morrill-Cornelius. J Genet Couns 2014

Next-generation sequencing for the diagnosis of hereditary breast and ovarian cancer using genomic capture targeting multiple candidate genes.
Laurent Castéra, Sophie Krieger, Antoine Rousselin, Angélina Legros, Jean-Jacques Baumann, Olivia Bruet, Baptiste Brault, Robin Fouillet, Nicolas Goardon, Olivier Letac,[...]. Eur J Hum Genet 2014

Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
Jonathan S Berg, Laura M Amendola, Christine Eng, Eliezer Van Allen, Stacy W Gray, Nikhil Wagle, Heidi L Rehm, Elizabeth T DeChene, Matthew C Dulik, Fuki M Hisama,[...]. Genet Med 2013

Cancer risk assessment using genetic panel testing: considerations for clinical application.
Susan Hiraki, Erica S Rinella, Freya Schnabel, Ruth Oratz, Harry Ostrer. J Genet Couns 2014

Collaboration of colorado cancer genetic counselors to integrate next generation sequencing panels into clinical practice.
K Wolfe Schneider, A Anguiano, L Axell, C Barth, K Crow, M Gilstrap, B A Hamlington, S Lesh, L Mullineaux, A Kulchak Rahm,[...]. J Genet Couns 2014

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients.
Holly LaDuca, A J Stuenkel, Jill S Dolinsky, Steven Keiles, Stephany Tandy, Tina Pesaran, Elaine Chen, Chia-Ling Gau, Erika Palmaer, Kamelia Shoaepour,[...]. Genet Med 2014

Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000

Qualitative data analysis for health services research: developing taxonomy, themes, and theory.
Elizabeth H Bradley, Leslie A Curry, Kelly J Devers. Health Serv Res 2007

Perspectives on post-treatment cancer care: qualitative research with survivors, nurses, and physicians.
Maria E Hewitt, Annette Bamundo, Rebecca Day, Catherine Harvey. J Clin Oncol 2007

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003

Translating genomics in cancer care.
Yvonne Bombard, Peter B Bach, Kenneth Offit. J Natl Compr Canc Netw 2013

Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members.
Heikki J Järvinen, Laura Renkonen-Sinisalo, Katja Aktán-Collán, Päivi Peltomäki, Lauri A Aaltonen, Jukka-Pekka Mecklin. J Clin Oncol 2009

Cancer patients' and patient advocates' perspectives on a novel information source: a qualitative study of the art of oncology, when the tumor is not the target.
Kristin S Vickers, Julie C Hathaway, Christi A Patten, Matthew M Clark, Teresa L Britt, Sherry A Looker, Phaedra T Johnson, Charles L Loprinzi. J Clin Oncol 2005

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995

Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.
Julie Lecarpentier, Valentina Silvestri, Karoline B Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Penny Soucy, Goska Leslie, Piera Rizzolo, Anna Sara Navazio,[...]. J Clin Oncol 2017

BRCA1 and BRCA2 families and the risk of skin cancer.
Ophira M Ginsburg, Charmaine Kim-Sing, William D Foulkes, Parviz Ghadirian, Henry T Lynch, Ping Sun, Steven A Narod. Fam Cancer 2010

Cowden's disease: a cutaneous marker of breast cancer.
M H Brownstein, M Wolf, J B Bikowski. Cancer 1978

BRCA1/2 mutation analysis in male breast cancer families from North West England.
D G R Evans, Mike Bulman, Karen Young, Emma Howard, Stuart Bayliss, Andrew Wallace, Fiona Lalloo. Fam Cancer 2008

Cancer risks among BRCA1 and BRCA2 mutation carriers.
E Levy-Lahad, E Friedman. Br J Cancer 2007

Germline BRCA Mutations in a Large Clinic-Based Cohort of Patients With Pancreatic Adenocarcinoma.
Spring Holter, Ayelet Borgida, Anna Dodd, Robert Grant, Kara Semotiuk, David Hedley, Neesha Dhani, Steven Narod, Mohammad Akbari, Malcolm Moore,[...]. J Clin Oncol 2015

Limited family structure and BRCA gene mutation status in single cases of breast cancer.
Jeffrey N Weitzel, Veronica I Lagos, Carey A Cullinane, Patricia J Gambol, Julie O Culver, Kathleen R Blazer, Melanie R Palomares, Katrina J Lowstuter, Deborah J MacDonald. JAMA 2007

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.
Fiona Lalloo, Jennifer Varley, David Ellis, Anthony Moran, Lindsay O'Dair, Paul Pharoah, D Gareth R Evans. Lancet 2003

Men in the women's world of hereditary breast and ovarian cancer--a systematic review.
Nina Strømsvik, Målfrid Råheim, Nina Oyen, Eva Gjengedal. Fam Cancer 2009

Preimplantation diagnosis for p53 tumour suppressor gene mutations.
Yury Verlinsky, Svetlana Rechitsky, Oleg Verlinsky, Kangu Xu, Glenn Schattman, Christina Masciangelo, Norman Ginberg, Charles Strom, Zev Rosenwaks, Anver Kuliev. Reprod Biomed Online 2001

Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
Jeffrey N Weitzel, Kathleen R Blazer, Deborah J MacDonald, Julie O Culver, Kenneth Offit. CA Cancer J Clin 2011

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel.
Nadine Tung, Chiara Battelli, Brian Allen, Rajesh Kaldate, Satish Bhatnagar, Karla Bowles, Kirsten Timms, Judy E Garber, Christina Herold, Leif Ellisen,[...]. Cancer 2015

Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Timothy R Rebbeck, Tara Friebel, Henry T Lynch, Susan L Neuhausen, Laura van 't Veer, Judy E Garber, Gareth R Evans, Steven A Narod, Claudine Isaacs, Ellen Matloff,[...]. J Clin Oncol 2004

Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories.
Renea A Taylor, Michael Fraser, Julie Livingstone, Shadrielle Melijah G Espiritu, Heather Thorne, Vincent Huang, Winnie Lo, Yu-Jia Shiah, Takafumi N Yamaguchi, Ania Sliwinski,[...]. Nat Commun 2017

Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Elizabeth K Bancroft, Elizabeth C Page, Elena Castro, Hans Lilja, Andrew Vickers, Daniel Sjoberg, Melissa Assel, Christopher S Foster, Gillian Mitchell, Kate Drew,[...]. Eur Urol 2014

Variants in the ATM gene associated with a reduced risk of contralateral breast cancer.
Patrick Concannon, Robert W Haile, Anne-Lise Børresen-Dale, Barry S Rosenstein, Richard A Gatti, Sharon N Teraoka, T Anh Diep, Laila Jansen, David P Atencio, Bryan Langholz,[...]. Cancer Res 2008

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.
April D Sorrell, Carin R Espenschied, Julie O Culver, Jeffrey N Weitzel. Mol Diagn Ther 2013

Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers.
T Golan, Z S Kanji, R Epelbaum, N Devaud, E Dagan, S Holter, D Aderka, S Paluch-Shimon, B Kaufman, R Gershoni-Baruch,[...]. Br J Cancer 2014

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2.
B B Roa, A A Boyd, K Volcik, C S Richards. Nat Genet 1996

CHEK2 (∗) 1100delC Mutation and Risk of Prostate Cancer.
Victoria Hale, Maren Weischer, Jong Y Park. Prostate Cancer 2014

Interest in genetic testing among affected men from hereditary prostate cancer families and their unaffected male relatives.
Julie N Harris, Deborah J Bowen, Alan Kuniyuki, Laura McIntosh, Liesel M FitzGerald, Elaine A Ostrander, Janet L Stanford. Genet Med 2009

Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
C J van Asperen, R M Brohet, E J Meijers-Heijboer, N Hoogerbrugge, S Verhoef, H F A Vasen, M G E M Ausems, F H Menko, E B Gomez Garcia, J G M Klijn,[...]. J Med Genet 2005

Hereditary breast and ovarian cancer: review and future perspectives.
Michael P Lux, Peter A Fasching, Matthias W Beckmann. J Mol Med (Berl) 2006

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.
Mark E Robson, Angela R Bradbury, Banu Arun, Susan M Domchek, James M Ford, Heather L Hampel, Stephen M Lipkin, Sapna Syngal, Dana S Wollins, Noralane M Lindor. J Clin Oncol 2015

Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.